Méhnyakrák: vizsgálatok itt: Fülöp-szigetek

1 trial · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

  Where

  Cebu City, Makati City, Manila

  Életkor

  18 év and over

  People

  1023 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07216703 · EU 2025-521514-26-00